MBAM
ENZ

Mink Brook Asset Management’s Enzo Biochem, Inc. ENZ Stock Holding History

Mink Brook Asset Management’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-807,899
Closed -$299K – 44
2025
Q1 		$299K Hold
807,899
– – 0.31% 24
2024
Q4 		$577K Buy
+807,899
New +$837K 0.55% 21

Other funds holding ENZ

RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
KCM
Kempner Capital Management Galveston, Texas $106M AUM 29.1% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return

Mink Brook Asset Management's ENZ Position: Q2 2025 in Review

Mink Brook Asset Management sold out of Enzo Biochem, Inc. (ENZ) in Q2 2025, closing a stake of 807,899 shares — an estimated $299K sold.

Mink Brook Asset Management first reported a position in ENZ in Q4 2024 and held it in 2 quarters. The position peaked at $577K in Q4 2024. 6 funds tracked by Wall St. Rank hold ENZ as of Q2 2025.

  • Mink Brook Asset Management reported no remaining Enzo Biochem, Inc. position as of Q2 2025 after selling out during the quarter.
  • Mink Brook Asset Management sold 807,899 Enzo Biochem, Inc. shares in Q2 2025, an estimated $299K.
  • Mink Brook Asset Management first reported a position in Enzo Biochem, Inc. in Q4 2024 and held it in 2 quarters.
  • Mink Brook Asset Management's Enzo Biochem, Inc. position peaked at $577K in Q4 2024.
  • 6 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2025.

Based on Mink Brook Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.